SCHEMBL6152587

SCHEMBL6152587

CCCc1cc2c(cc1OC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Br)OCO2

nearest known ligand 0.73

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 20/20 0.73
EDNRB P24530 16/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6151576 0.84 EDNRA (1.00) EDNRAEDNRB
SCHEMBL4631547 0.84 EDNRB (1.00) EDNRAEDNRB
SCHEMBL4632010 0.80 EDNRB (1.00) EDNRAEDNRB
SCHEMBL4630645 0.79 EDNRA (1.00) EDNRAEDNRB
SCHEMBL6151584 0.79 EDNRA (1.00) EDNRAEDNRB
SCHEMBL6151568 0.79 EDNRA (1.00) EDNRAEDNRB
SCHEMBL4631332 0.78 EDNRA (1.00) EDNRAEDNRB
SCHEMBL6151330 0.78 EDNRA (0.84) EDNRAEDNRB
SCHEMBL9063334 0.78 EDNRA (1.00) EDNRAEDNRB
SCHEMBL4631503 0.78 EDNRA (1.00) EDNRAEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5962490-A Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin TEXAS BIOTECHNOLOGY CORPORATION (US) 1999-10-05 US claimed
EP-0980369-B1 SULFONAMIDES FOR TREATMENT OF ENDOTHELIN-MEDIATED DISORDERS ENCYSIVE PHARMACEUTICALS INC (US) 2005-03-30 EP disclosed
EP-1498419-A1 Process for preparing alkali metal salts of hydrophobic sulfonamides ENCYSIVE PHARMACEUTICALS INC. (US) 2005-01-19 EP disclosed
EP-1498418-A1 Sulfonamides for treatment of endothelin-mediated disorders ENCYSIVE PHARMACEUTICALS INC. (US) 2005-01-19 EP disclosed
EP-0946552-B1 SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN ENCYSIVE PHARMACEUTICALS INC (US) 2004-07-07 EP disclosed